Equity Overview
Price & Market Data
Price: $1.50
Daily Change: -$0.025 / 1.67%
Range: $1.43 - $1.54
Market Cap: $20,222,850
Volume: 32,962
Performance Metrics
1 Week: -3.23%
1 Month: -24.62%
3 Months: -45.05%
6 Months: -62.78%
1 Year: -67.32%
YTD: -57.63%
Company Details
Employees: 14
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated (CRAC) channel inhibitors, which is in phase 2 clinical trials for the treatment of acute pancreatitis, asparaginase induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also develops Auxora, for the treatment of acute ulcerative colitis and allergic asthma. The company is based in La Jolla, California.